Endoscopic sleeve gastroplasty
Endoscopic sleeve gastroplasty is a medical procedure with 13 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
80.0%
4 of 5 finished
20.0%
1 ended early
3
trials recruiting
13
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Hormonal and Microbiota Modulation After Endoscopic Sleeve Gastroplasty
Effectiveness of Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Hybrid Argon Plasma Coagulation and Endoscopic Sleeve Gastroplasty Validation Study
Endoscopic Sleeve Gastroplasty for Obesity and Microbiota Randomized Trial
Clinical Trials (13)
Hormonal and Microbiota Modulation After Endoscopic Sleeve Gastroplasty
Effectiveness of Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Hybrid Argon Plasma Coagulation and Endoscopic Sleeve Gastroplasty Validation Study
Endoscopic Sleeve Gastroplasty for Obesity and Microbiota Randomized Trial
Endoscopic Sleeve Gastroplasty
Endoscopic Sleeve Gastroplasty Versus GLP-1 Analogue for Class 1 and 2 Obesity Study
Safety, Tolerability, and Sustained Weight Loss of Endoscopic Sleeve Gastroplasty With Diet Modification and Exercise
Hormonal and Metabolic Aspects of Endoscopic Sleeve Gastroplasty
ESG vs LSG: Short-term Nutritional Outcomes
Endosleeve in Adolescents
Endoscopic Sleeve Gastroplasty for Morbid Obesity
Endoscopic Sleeve Gastroplasty for Treatment of Obesity
All 13 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 13